Clostridium histolyticum Collagenase Inhibitors in the Drug Design

Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications

Volumn , Issue , 2009, Pages 721-729

  Supuran, Claudiu T ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Drug design Clostridium histolyticum collagenase inhibitors; Fatty acids as ChC inhibitors; Hydroxamates as ChC inhibitors

Indexed keywords

EID: 84860382431     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470508169.ch30     Document Type: Chapter

References (30)

1. Barrett, A.J.; Rawlings, N.D.; Woessner, J.F., Jr., Eds. Handbook of Proteolytic Enzymes (CD-ROM); Academic Press: London, 1998; Chapters 1-569.
2. Jung,C.M.; Matsushita,O.; Katayama, S.;Minami, J.; Sakurai, J.; Okabe,A. Identification of metal ligands in the Clostridium histolyticum ColH collagenase. J. Bacteriol. 1999, 181, 2816-2822.
3. Matsushita, O.; Jung, C. M.; Minami, J.; Katayama, S.; Nishi, N.; Okabe, A. A study of the collagen-binding domain of a 116-kDa Clostridium histolyticum collagenase. J. Biol. Chem. 1998, 273, 3643-3648.
4. Eckhard, U.; Schönauer, E.; Ducka, P.; Briza, P.; Nüss, D.; Brandstetter, H. Biochemical characterization of the catalytic domains of three different clostridial collagenases. Biol. Chem. 2009, 390, 11-18.
5. Van Wart, H.E. Clostridium collagenase. Handbook of Proteolytic Enzymes (CD-ROM); Barrett, A.J.; Rawlings, N.D.; Woessner, J.F., Jr., Eds.; Academic Press: London, 1998; Chapter 368.
6. Bond, M. D.; Van Wart, H. E. Purification and separation of individual collagenases of Clostridium histolyticum using red dye ligand chromatography. Biochemistry 1984, 23, 3077-3085.
7. Bond, M. D.; Van Wart, H. E. Characterization of the individual collagenases from Clostridium histolyticum. Biochemistry 1984, 23, 3085-3091.
8. Jung, W.; Winter, H. Considerations for the use of clostridial collagenase in clinical practice. Clin. Drug Invest. 1998, 15, 245-252.
9. Eckhard, U.; Nüss, D.; Ducka, P.; Schönauer, E.; Brandstetter, H. Crystallization and preliminary X-ray characterization of the catalytic domain of collagenase G from Clostridium histolyticum. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2008, 64, 419-421.
10. Scozzafava, A.; Supuran, C. T. Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties. J. Med. Chem. 2000, 43, 1858-1865.
11. Valee, B. L.; Auld, D. S. Zinc coordination, function and structure of zinc enzymes and other proteins. Biochemistry 1990, 29, 5647-5659.
12. Larsen, K. S.; Zhang, K.; Auld, D. S. D-Phe complexes of zinc and cobalt carboxypeptidase A. J. Inorg. Biochem. 1996, 64, 149-162.
13. Scozzafava, A.; Supuran, C. T. Carbonic anhydrase and matrix metalloproteinase inhibitors. Sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of carbonic anhydrase isozymes I, II and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes. J. Med. Chem. 2000, 43, 3677-3687.
14. Scozzafava, A.; Supuran, C. T. Protease inhibitor. Part 5. Alkyl/arylsulfonyl- and arylsulfonylureido-/arylureido-glycine hydroxamate inhibitors of Clostridium histolyticum collagenase. Eur. J. Med. Chem. 2000, 35, 299-307.
15. Supuran, C. T.; Briganti, F.; Mincione, G.; Scozzafava, A. Protease inhibitors: synthesis of L-alanine hydroxamate sulfonylated derivatives as inhibitors of Clostridium histolyticum collagenase. J. Enzyme Inhib. 2000, 15, 111-128.
16. Supuran, C. T.; Scozzafava, A. Protease inhibitor. Part 7. Inhibition of Clostridium histolyticum collagenase with sulfonylated derivatives of L-valine hydroxamate. Eur. J. Pharm. Sci. 2000, 10, 67-76.
17. Scozzafava, A.; Supuran, C. T. Protease inhibitor. Part 8. Synthesis of potent Clostridium histolyticum collagenase inhibitors incorporating sulfonylated L-alanine hydroxamate moieties. Bioorg. Med. Chem. 2000, 8, 637-645.
18. Scozzafava, A.; Supuran, C. T. Protease inhibitor. Part 9. Synthesis of Clostridium histolyticum collagenase inhibitors incorporating sulfonyl-L-alanine hydroxamate moieties. Bioorg. Med. Chem. Lett. 2000, 10, 499-502.
19. Scozzafava, A.; Ilies, M.A.;Manole, G.; Supuran,C.T. Protease inhibitor. Part 12. Synthesis of potent matrix metalloproteinase and bacterial collagenase inhibitors incorporating sulfonylatedN-4-nitrobenzyl-b-alanine hydroxamate moieties.Eur. J. Pharm. Sci. 2000, 11, 69-79.
20. Clare, B. W.; Scozzafava, A.; Supuran, C. T. Protease inhibitors. Synthesis of a series of bacterial collagenase inhibitors of the sulfonyl amino acyl hydroxamate type. J. Med. Chem. 2001, 44, 2253-2258.
21. Ilies, M.; Banciu, M. D.; Scozzafava, A.; Ilies, M. A.; Caproiu, M. T.; Supuran, C. T. Protease inhibitors: synthesis of bacterial collagenase and matrix metalloproteinase inhibitors incorporating arylsulfonylureido and 5-dibenzo-suberenyl/suberyl moieties. Bioorg. Med. Chem. 2003, 11, 2227-2239.
22. Santos, M. A.; Marques, S.; Gil, M.; Tegoni, M.; Scozzafava, A.; Supuran, C. T. Protease inhibitors: synthesis of bacterial collagenase and matrix metalloproteinase inhibitors incorporating succinyl hydroxamate and iminodiacetic acid hydroxamate moieties. J. Enzyme Inhib. Med. Chem. 2003, 18, 233-242.
23. Supuran, C. T.; Clare, B. W. Quantum theoretic QSAR of benzene derivatives: some enzyme inhibitors. J. Enzyme Inhib. Med. Chem. 2004, 19, 237-248.
24. Scozzafava, A.; Supuran, C. T. Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions. Bioorg. Med. Chem. Lett. 2002, 12, 2667-2672.
25. Rennert, B.; Melzig, M. F. Free fatty acids inhibit the activity of Clostridium histolyticum collagenase and human neutrophil elastase. Planta Med. 2002, 68, 767-769.
26. Clinch, T. E.; Hobden, J. A.; Hill, J. M.; O'Callaghan, R. J.; Engel, L. S.; Kaufmann, H. E. Collagen shields containing tobramycin for sustained therapy (24 hours) of experimental Pseudomonas keratitis. CLAO J. 1992, 18, 245-247.
27. Kuwano, M.; Horibe, Y.; Kawashima, Y. Effect of collagen cross-linking in collagen corneal shields on ocular drug delivery. J. Ocul. Pharmacol. Ther. 1997, 13, 31-40.
28. Harding, K. G.; Bale, S.; Llewellyn, M.; Baggot, J.; Robbins, K. A pilot study of Clostridium collagenase (Collagenase ABC(TM)) ointment in the debridement of dermal ulcers. Clin. Drug Invest. 1996, 11, 139-144.
29. Jung, W.; Winter, H. Considerations for the use of clostridial collagenase in clinical practice. Clin. Drug Invest. 1998, 15, 245-252.
30. Metzmacher, I.; Ruth, P.; Abel, M.; Friess,W. In vitro binding of matrix metalloproteinase-2 (MMP-2), MMP-9, and bacterial collagenase on collagenous wound dressings. Wound Repair Regen. 2007, 15, 549-555.